• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于比较两个对事件发生时间具有预后价值的相关标志物的统计量。

A statistic for comparing two correlated markers which are prognostic for time to an event.

作者信息

Jung S H, Wieand S, Cha S S

机构信息

Division of Biostatistics, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Stat Med. 1995 Oct 30;14(20):2217-25. doi: 10.1002/sim.4780142005.

DOI:10.1002/sim.4780142005
PMID:8552898
Abstract

A proliferation of biologic markers has led to increased interest in methods for comparing the prognostic value of markers in predicting time to recurrence of or death from disease. This paper proposes a nonparametric test statistic for comparing two continuous markers when the outcome of interest is time to an event and the outcome is subject to right censoring. Results from Monte Carlo studies show that the new testing procedure is reliable for practical use. We present an example in which we use the statistic successfully in a colon cancer study to select between two potentially useful markers.

摘要

生物标志物的大量涌现使得人们对比较标志物在预测疾病复发时间或死亡时间方面的预后价值的方法越来越感兴趣。本文提出了一种非参数检验统计量,用于比较两个连续标志物,此时感兴趣的结果是事件发生时间且结果存在右删失。蒙特卡罗研究结果表明,新的检验程序在实际应用中是可靠的。我们给出一个例子,其中我们在一项结肠癌研究中成功地使用该统计量在两个潜在有用的标志物之间进行选择。

相似文献

1
A statistic for comparing two correlated markers which are prognostic for time to an event.一种用于比较两个对事件发生时间具有预后价值的相关标志物的统计量。
Stat Med. 1995 Oct 30;14(20):2217-25. doi: 10.1002/sim.4780142005.
2
Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.miR-24-3p的高表达是结直肠癌潜在的不良预后因素。
Clin Biochem. 2017 Apr;50(6):285-292. doi: 10.1016/j.clinbiochem.2016.11.034. Epub 2016 Dec 7.
3
Flow cytometry in colon cancer: does flow cytometric cell cycle analysis help predict for short-term recurrence in patients with colorectal carcinoma?结肠癌中的流式细胞术:流式细胞术细胞周期分析有助于预测结直肠癌患者的短期复发吗?
J Natl Med Assoc. 1995 Nov;87(11):803-6.
4
Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study.常规腹膜细胞学对结直肠癌和胃癌无预后意义:EVOCAPE 2 多中心前瞻性研究结果。
Eur J Surg Oncol. 2013 Jul;39(7):707-14. doi: 10.1016/j.ejso.2013.03.021. Epub 2013 Apr 17.
5
Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?血清CA19-9在结直肠癌患者的管理中是否发挥实际作用?
Dis Colon Rectum. 2004 Feb;47(2):227-32. doi: 10.1007/s10350-003-0041-6.
6
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.DNA倍体和S期分数可预测结直肠癌患者的预后,而p53或NM23-H1表达则不能。一项5年前瞻性研究的结果。
J Cancer Res Clin Oncol. 2002 Dec;128(12):650-8. doi: 10.1007/s00432-002-0394-6. Epub 2002 Nov 15.
7
Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.分子标志物是 Dukes B 期和 Dukes C 期结直肠癌患者复发和生存的预测指标。
Dis Colon Rectum. 2001 Apr;44(4):523-33. doi: 10.1007/BF02234324.
8
Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.肿瘤定位对结直肠癌中P53蛋白预后价值的影响。
Anticancer Res. 2000 Sep-Oct;20(5C):3907-12.
9
Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.流式细胞术DNA倍体和S期分数与结直肠癌肿瘤行为的组织病理学指标相关。
Dis Colon Rectum. 1997 Apr;40(4):411-9. doi: 10.1007/BF02258385.
10
Using a surrogate marker for early testing of a treatment effect.使用替代标志物进行治疗效果的早期检测。
Biometrics. 2019 Dec;75(4):1253-1263. doi: 10.1111/biom.13067. Epub 2019 Apr 22.

引用本文的文献

1
A Dunnett-Type Test and Its Sample Size Calculation for Comparing ROC Curves with a Control.一种用于将ROC曲线与对照进行比较的Dunnett型检验及其样本量计算
Diagnostics (Basel). 2024 Aug 20;14(16):1813. doi: 10.3390/diagnostics14161813.
2
Fluid overload and outcomes in neonates receiving continuous renal replacement therapy.接受连续性肾脏替代治疗的新生儿的液体超负荷与预后
Pediatr Nephrol. 2016 Nov;31(11):2145-52. doi: 10.1007/s00467-016-3363-z. Epub 2016 Mar 14.